Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antibodies as Mediators of Brain Pathology.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Relapsing optic neuritis: a multicentre study of 62 patients.
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
Goal oriented inpatient multiple sclerosis group.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Multiple sclerosis: Creating a STIR-MRI sequence improves detection of spinal cord lesions.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Reducing clinical trial risk in multiple sclerosis.
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis.
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Treatment Issues in Multiple Sclerosis in Latin America.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
[Towards a nursing consultation in neurosexology].

Pages